Filter
301
Text search:
vaccine
trial
Featured
Recommendations
32
New Publications
48
Language
Document type
No document type
129
Studies & Reports
59
Guidelines
56
Fact sheets
14
Manuals
11
Strategic & Response Plan
10
Training Material
7
Situation Updates
7
Resource Platforms
6
App
1
Infographics
1
Countries / Regions
Global
14
Kenya
8
India
6
East and Southern Africa
6
West and Central Africa
6
Eastern Europe
6
Russia
6
Uganda
5
South Africa
5
Brazil
5
Africa
5
Sierra Leone
4
Liberia
4
Nigeria
4
Zimbabwe
4
Middle East and North Africa
4
Western and Central Europe
4
Bangladesh
3
Latin America and the Carribbean
3
Ghana
2
South Sudan
2
Zambia
2
Cambodia
2
Malawi
2
Ukraine
2
Guinea
1
Congo, Democratic Republic of
1
Ethiopia
1
Philippines
1
Nepal
1
Syria
1
Tanzania
1
Rwanda
1
Indonesia
1
Mozambique
1
Papua New Guinea
1
Sudan
1
Honduras
1
Ecuador
1
Lesotho
1
Myanmar / Burma
1
Chile
1
Yemen
1
South–East Asia Region
1
Western Pacific Region
1
Asia
1
Venezuela
1
Southern Africa
1
Laos
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
74
Clinical Guidelines
37
Women & Child Health
23
Public Health
13
Key Resources
7
Pharmacy & Technologies
2
Toolboxes
COVID-19
77
TB
34
HIV
27
NTDs
23
Ebola & Marburg
10
AMR
9
Rapid Response
8
Mental Health
6
Pharmacy
6
Polio
5
Global Health Education
4
Planetary Health
4
NCDs
4
Zika
3
Malaria
2
Disability
1
Cholera
1
Conflict
1
Refugee
1
Caregiver
1
2.0 Rapid Response
1
September 2021
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pa
...
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
WHO Secretariat Information paper July 2016
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of
...
Protection from a Single Dose of HPV Vaccine A major public health impact from IARC studies of vaccine efficacy.
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the back
...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident
...
AstraZeneca-SKBio in South Korea and Serum Institute of India
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary include
...
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
This quick guide offers basic information about COVID-19, the Sinovac-CoronaVac COVID-19 vaccine and what to
expect following vaccination: ...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
COVID-19 Vaccine Resource Center
recommended
A collection of resources on Covid-19 vaccines, including frequently asked questions, continuing medical education, published research, and commentary.
